Sterol O-acyltransferase 1 (SOAT1) was involved in cholesterol metabolism and showed an increasing trend as a member of Cluster 1, and has been considered a potential therapeutic target of early-stage HCC [2]. This evidence concerns the gene SOAT1 and hepatocellular carcinoma.